+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Affairs Outsourcing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 172 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5635653

The NIH invests about USD 417 Bn annually in medical research for the American people

The Global Medical Affairs Outsourcing Market is estimated to be USD 7.89 Bn in 2022 and is expected to reach USD 14.6 Bn by 2027, growing at a CAGR of 13.1%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Medical Affairs Outsourcing Market is segmented based on Service, End User, and Geography.
  • By Service, the market is classified into Clinical Trial Applications and Product Registrations, Regulatory Consulting and Legal Representation, and Regulatory Writing and Publishing.
  • By End User, the market is classified into Biotechnology Companies, Mid- Sized Pharmaceutical Companies, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Accell Clinical Research, Charles River Laboratories International, Inc., Clinilabs, Inc., Covance, Inc.,, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Medical Affairs Outsourcing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Medical Affairs Outsourcing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Medical Affairs Outsourcing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Adoption of Cost-Saving Measures with Changing Reimbursement Policies in Pharmaceutical Sector
4.1.2 Potential Demand Attributed to High Cost Involved in Training and R&D Process
4.1.3 Availability of Price-Efficient Solutions and Compliance with Regulator
4.2 Restraints
4.2.1 High Cost Involved in R&D of the Pharmaceutical Sector
4.3 Opportunities
4.3.1 Surge in Outsourcing of Medical Affairs
4.4 Challenges
4.4.1 Concerns Over Data Breaches and Security
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Medical Affairs Outsourcing Market, By Service
6.1 Introduction
6.2 Clinical Trial Applications and Product Registrations
6.3 Regulatory Consulting and Legal Representation
6.4 Regulatory Writing and Publishing
7 Global Medical Affairs Outsourcing Market, By End User
7.1 Introduction
7.2 Biotechnology Companies
7.3 Mid- Sized Pharmaceutical Companies
7.4 Others
8 Americas' Medical Affairs Outsourcing Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's Medical Affairs Outsourcing Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's Medical Affairs Outsourcing Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's Medical Affairs Outsourcing Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Accell Clinical Research
13.2 Charles River Laboratories International, Inc
13.3 Clinilabs, Inc
13.4 Covance, Inc
13.5 Criterium, Inc
13.6 Genpact Ltd
13.7 ICON plc
13.8 Medpace, Inc
13.9 PARAXEL International Corp
13.10 Pharmaceutical Product Development, LLC
13.11 PRA Health Sciences, Inc
13.12 Promedica International
13.13 Quintiles Transnational Corp
13.14 WuXi AppTec Group
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Accell Clinical Research
  • Charles River Laboratories International, Inc Clinilabs, Inc Covance, Inc Criterium, Inc Genpact Ltd
  • ICON plc
  • Medpace, Inc PARAXEL International Corp Pharmaceutical Product Development, LLC
  • PRA Health Sciences, Inc Promedica International
  • Quintiles Transnational Corp WuXi AppTec Group